Singh, D., McMillan, J., Hilaire, J., Gautam, N., Palandri, D., Alnouti, Y., . . . Edagwa, B. (2016). Development and characterization of a long-acting nanoformulated abacavir prodrug. Nanomedicine (Lond).
Stile di citazione ChicagoSingh, Dhirender, JoEllyn McMillan, James Hilaire, Nagsen Gautam, Diana Palandri, Yazen Alnouti, Howard E. Gendelman, e Benson Edagwa. "Development and Characterization of a Long-acting Nanoformulated Abacavir Prodrug." Nanomedicine (Lond) 2016.
Citazione MLASingh, Dhirender, et al. "Development and Characterization of a Long-acting Nanoformulated Abacavir Prodrug." Nanomedicine (Lond) 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.